entertainment -WSS

entertainment

author：focus 2025-09-30 17:44:39 - browse：67

A phone screen displays the webpage of Medicare.gov — coverage from STAT — Adobe

Over the past few weeks, Medicare Advantage insurers demanded that the Biden administration give them higher payment rates for next year. The government’s data on how much people were using health care didn’t match their own data, insurers and lobbyists griped — and therefore they wouldn’t be paid enough to cover those costs.

But the federal government was not persuaded by the industry’s data or lobbying push. The Biden administration and its Medicare agency decided to stick with their proposals from January on Monday, dealing a blow to an insurance industry that has come to rely on Medicare Advantage for a steady stream of profits.

The result: In 2025, right after a new president is elected, Medicare Advantage insurers will have to absorb a slight decrease of 0.2% to the baseline payment rates that insurers receive from the government for enrolling older adults and people with disabilities. The stock prices of the largest Medicare Advantage insurers — UnitedHealth, Humana, CVS Health, and Elevance Health — all fell by at least 4% in after-hours trading.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Senators start work on Medicare physician payment reform

WSS

Why medical students are struggling with mental health

PBM reforms clear House panel

How digital tools helped lower hypertension in marginalized patients

Gain of function research would be limited under House proposal

Astellas still sees hope in its gene therapy after four deaths

Poor hospice wound care hurts patients and families

hotspot

entertainment

Wikipedia

Trump demands the U.S. pay no more for drugs than other countries … again

Medical mystery: When a cough is not just a cough

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

CRISPR pioneers react to Casgevy, first gene

What does generative AI mean for health care? We asked experts

A disappointing year of Humira biosimilars

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Vaccine advisory panel ACIP left half staffed by HHS

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

leisure time

Congress must reauthorize a committee to support older Americans

Medicare Advantage proposed rates disappoint insurers

World's first CRISPR

Vaccine advisory panel ACIP left half staffed by HHS

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

FDA's Woodcock to retire early next year

entertainment

explore

Wikipedia

entertainment